Breaking News

Systech Releases Exception Handling and Rework Solution

Offers quick compliance, avoids delays, and optimizes production with multi-scan and mobile flexibility.

Systech, a provider of digital identification and traceability software solutions, has released a comprehensive and versatile rework offering for managing exceptions in the pharmaceutical supply chain. Built on Systech’s expertise with rework across the stack, it delivers robust capabilities from the line through the supply chain to help manufacturers, CMOs, CPOs and distributors minimize data misalignment, product delays and associated risks in the pharmaceutical sector.

Exception management focuses on identifying and resolving issues arising during pharmaceutical product manufacturing and distribution. It is critical in the pharmaceutical sector due to patient safety and regulatory compliance concerns and to avoid supply chain delays and product quarantine.

As trading partners continue to implement and fine-tune their processes to adhere to the DSCSA guidelines and systems, the volume of errors related to discrepancies between the data received and the product received in the shipment are expected to grow 5 to 10x. Considering the increasing challenges related to counterfeits, drug shortages and patient safety, efficient handling of exceptions becomes imperative.

As a full stack solution provider, Systech’s solution uniquely offers comprehensive rework starting on the line and through the supply chain, with rapid deployment, seamless connectivity to any Level 4 platform and a built-in data inspector with the flexibility to adapt to any workflow and ecosystem.

“Our new feature-rich, exception handling solution addresses a diverse set of use cases, leveraging our vast experience in providing rework up and down the stack and ensuring seamless trading partner connectivity,” said Sreedhar Patnala, Vice President of Digital Products at Systech. “Systech’s highly reliable and scalable solutions effectively mitigate risk and keep the data and product moving.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters